A study in Diabetes Care showed that the rapid decline in estimated glomerular filtration rate among type 2 diabetes patients may be predicted by the novel plasma biomarkers CD5 antigen-like, complement C1q subcomponent subunit B and plasma apolipoprotein A-IV, along with insulin-like growth factor binding protein 3. Australian researchers used semiparametric group-based modeling to identify the clinical predictors of rapid eGFR decline in a cohort of 345 community-based patients from the Fremantle Diabetes Study Phase II.
Researchers ID biomarkers that predict renal function decline in diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.